Judgment of the Court (Fourth Chamber) of 21 March 2019
Abraxis Bioscience LLC v Comptroller General of Patents
Request for a preliminary ruling from the High Court of Justice (England & Wales), Chancery Division (patents court)
Reference for a preliminary ruling — Medicinal product for human use — Supplementary protection certificate for medicinal products — Regulation (EC) No 469/2009 — Article 3(d) — Conditions for granting — Grant of first authorisation to place the product on the market as a medicinal product — Authorisation covering a product as a medicinal product constituting a new formulation of a known active ingredient
Case C-443/17
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Opinion
ECLI:EU:C:2018:1020 |
|
|
|
Judgment
ECLI:EU:C:2019:238 |
|
|
|